Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum

Citation
Kd. Kuppenbender et al., Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum, J COMP NEUR, 419(4), 2000, pp. 407-421
Citations number
88
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF COMPARATIVE NEUROLOGY
ISSN journal
00219967 → ACNP
Volume
419
Issue
4
Year of publication
2000
Pages
407 - 421
Database
ISI
SICI code
0021-9967(20000417)419:4<407:EONRSM>2.0.ZU;2-W
Abstract
N-methyl-D-aspartate (NMDA) receptors are composed of subunits from two fam ilies: NR1 and NR2. We used a dual-label in situ hybridization technique to assess the levels of NR1 and NR2A-D messenger ribonucleic acid (mRNA) expr essed in projection neurons and interneurons of the human striatum. The neu ronal populations were identified with digoxigenin-tagged complementary RNA probes for preproenkephalin (ENK) and substance P (SP) targeted to striata l projection neurons, and somatostatin (SOM), glutamic acid decarboxylase 6 7 kD (GAD(67)), and choline acetyltransferase (ChAT) targeted to striatal i nterneurons. Intense NR1 signals were found over all striatal neurons. NR2A signals were high over GAD(67)-positive neurons and intermediate over SP-p ositive neurons. ENK-positive neurons displayed low NR2A signals, whereas C hAT- and SOM-positive neurons were unlabeled. NR2B signals were intense ove r all neuronal populations in striatum. Signals for NR2C and NR2D were weak . Only ChAT-positive neurons displayed moderate signals, whereas all other interneurons and projection neurons were unlabeled. Moderate amounts of NR2 D signal were detected over SOM- and ChAT-positive neurons; GAD(67)- and SP -positive striatal neurons displayed low and ENK-positive neurons displayed no NR2D hybridization signal. These data suggest that all human striatal n eurons have NMDA receptors, but different populations have different subuni t compositions that may affect function as well as selective vulnerability. J. Comp. Neurol. 419:407-421, 2000. (C) 2000 Wiley-Liss, Inc.